318 related articles for article (PubMed ID: 5923162)
1. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
[No Abstract] [Full Text] [Related]
2. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
[No Abstract] [Full Text] [Related]
3. The carcinostatic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone.
Blanz EJ; French FA
Cancer Res; 1968 Dec; 28(12):2419-22. PubMed ID: 5728150
[No Abstract] [Full Text] [Related]
4. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
5. The carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. 3. Primary correlation.
French FA; Blanz EJ
J Med Chem; 1966 Jul; 9(4):585-9. PubMed ID: 5968028
[No Abstract] [Full Text] [Related]
6. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
Booth BA; Agrawal KC; Moore EC; Sartorelli AC
Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
[No Abstract] [Full Text] [Related]
7. Synthesis and antitumor activity of 3- and 5-hydroxy-4-methylpyridine-2-carboxaldehyde thiosemicarbazones.
Wang Y; Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3667-71. PubMed ID: 1433177
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
Mihich E; Nichol CA
Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
[No Abstract] [Full Text] [Related]
9. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
[TBL] [Abstract][Full Text] [Related]
10. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
Mihich E; Nichol CA
Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
[No Abstract] [Full Text] [Related]
11. Antitumor activity of periodate-oxidation products of carbohydrates and their derivatives.
Dvonch W; Fletcher H; Gregory FJ; Healy EM; Warren GH; Alburn HE
Cancer Res; 1966 Nov; 26(11):2386-9. PubMed ID: 4289174
[No Abstract] [Full Text] [Related]
12. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituents.
Blanz EJ; French FA; DoAmaral JR; French DA
J Med Chem; 1970 Nov; 13(6):1124-30. PubMed ID: 5273758
[No Abstract] [Full Text] [Related]
13. Antitumor activity of N-heterocyclic carboxaldehyde thiosemicarbazone derivatives.
Iigo M; Hoshi A; Kuretani K; Natsume M
Gan; 1977 Apr; 68(2):221-5. PubMed ID: 892296
[TBL] [Abstract][Full Text] [Related]
14. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
[TBL] [Abstract][Full Text] [Related]
16. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
17. An approach to tumour biology in the light of prevention, cure and etiology.
Bose S; Chowdhury JR
Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
[No Abstract] [Full Text] [Related]
18. [Antineoplastic properties of complex compounds of platinum(II)].
Presnov MA; Konovalova AL; Stetsenko AI; Ivanov VF; Iakovlev KI
Dokl Akad Nauk SSSR; 1976 Oct; 230(6):1357-9. PubMed ID: 976058
[No Abstract] [Full Text] [Related]
19. Cell-kill kinetics of several S-phase-specific drugs.
Bhuyan BK; Fraser TJ; Gray LG; Kuentzel SL; Neil GL
Cancer Res; 1973 Apr; 33(4):888-94. PubMed ID: 4735241
[No Abstract] [Full Text] [Related]
20. [Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
Shorin VA; Averbukh LA; Bazhanov VS; Lepeshkina GN; Grinshteĭn AM
Antibiotiki; 1972 Aug; 17(8):675-80. PubMed ID: 4678532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
